More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the fully humanised immunoglobulin G4 (IgG4) antibody, imsidolimab, to treat ...